BeOne Medicines (ONC) Net Margin (2015 - 2026)
BeOne Medicines (ONC) posted quarterly Net Margin of 15.02% for Q1 2026, up 1491.0% year-over-year from 0.94% in Q1 2025, and up 238.43% quarter-over-quarter from 4.44% in Q4 2025.
Powered by 
Analysis
BeOne Medicines (ONC) Net Margin (2015 - 2026) Analysis & Trends
BeOne Medicines (ONC) has reported Net Margin for 12 consecutive years, with 15.02% the latest figure, recorded in Q1 2026.
- In Q1 2026, Net Margin rose 1491.0% year-over-year to 15.02%; the TTM figure through Mar 2026 stood at 8.94% (up 1833.0% YoY), while the FY2025 annual figure was 5.37%, up 2229.0% from the prior year.
- Net Margin advanced to 15.02% in Q1 2026 per ONC's latest filing, from 4.44% in the prior quarter.
- Across five years, Net Margin topped out at 27.57% in Q3 2023 and bottomed at 165.62% in Q2 2022.
- Historically, Net Margin has averaged 45.71% across 5 years, with a median of 13.47% in 2024.
- Annual changes were most pronounced in 2022 — Net Margin tumbled 15291 bps — and 2023, when it soared 17141 bps.
- BeOne Medicines' Net Margin stood at 117.16% in 2022, then surged by 51 bps to 57.94% in 2023, then jumped by 77 bps to 13.47% in 2024, then soared by 133 bps to 4.44% in 2025, then jumped by 238 bps to 15.02% in 2026.
- Business Quant data shows ONC's Net Margin at 15.02% in Q1 2026, 4.44% in Q4 2025, and 8.84% in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 32.99% |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 30.23% |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 31.16% |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -539.31% |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 13.90% |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 12.74% |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 12.09% |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -3.12% |
| 10 | Incyte | 25.44 Bn | 20.91 Bn | 1.57 Bn | 34.98% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 13.90% |
| Mar 31, 2026 | 15.02% |
| Dec 31, 2025 | 4.44% |
| Sep 30, 2025 | 8.84% |
| Jun 30, 2025 | 7.17% |
| Mar 31, 2025 | 0.11% |
| Dec 31, 2024 | -13.47% |
| Sep 30, 2024 | -12.12% |
| Jun 30, 2024 | -12.96% |
| Mar 31, 2024 | -33.41% |
| Dec 31, 2023 | -57.94% |
| Sep 30, 2023 | 27.57% |
| Jun 30, 2023 | -64.03% |
| Mar 31, 2023 | -77.81% |
| Dec 31, 2022 | -117.16% |
| Sep 30, 2022 | -143.84% |
| Jun 30, 2022 | -165.62% |
| Mar 31, 2022 | -141.93% |
| Dec 31, 2021 | -276.04% |
| Sep 30, 2021 | -212.22% |